In this work, via introducing a competitive-SELEX procedure, accompanied by using NaCl as an elution system, we endeavor to develop aptamer sequences eligible not only for CD63 positive tumor detection, but also for the development of novel immunoaffinity strategy, enabling the separation of natural state exosomes for various basic and applied applications. Here, CD63 is linked to neoplasm.